000 01517 a2200433 4500
005 20250517110926.0
264 0 _c20170228
008 201702s 0 0 eng d
022 _a1556-9519
024 7 _a10.1080/15563650.2016.1211288
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBäckberg, Matilda
245 0 0 _aAdverse events related to the new psychoactive substance 3-fluorophenmetrazine - results from the Swedish STRIDA project.
_h[electronic resource]
260 _bClinical toxicology (Philadelphia, Pa.)
_cNov 2016
300 _a819-825 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aChromatography, Liquid
_xmethods
650 0 4 _aEmergency Service, Hospital
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIllicit Drugs
_xblood
650 0 4 _aIntensive Care Units
650 0 4 _aMale
650 0 4 _aMass Spectrometry
_xmethods
650 0 4 _aMiddle Aged
650 0 4 _aPhenmetrazine
_xanalogs & derivatives
650 0 4 _aPsychotropic Drugs
_xblood
650 0 4 _aRetrospective Studies
650 0 4 _aSeverity of Illness Index
650 0 4 _aSubstance Abuse Detection
_xmethods
650 0 4 _aSweden
_xepidemiology
650 0 4 _aYoung Adult
700 1 _aWesterbergh, Jenny
700 1 _aBeck, Olof
700 1 _aHelander, Anders
773 0 _tClinical toxicology (Philadelphia, Pa.)
_gvol. 54
_gno. 9
_gp. 819-825
856 4 0 _uhttps://doi.org/10.1080/15563650.2016.1211288
_zAvailable from publisher's website
999 _c26297813
_d26297813